BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27848228)

  • 1. High levels of DNA polymerase β mRNA corresponding with the high activity in Graves' thyroid tissue.
    Hayakawa N; Sato Y; Nagasaka A; Mano Y; Nagasaka T; Nakai A; Iwase K; Yoshida S
    J Endocrinol Invest; 2017 Apr; 40(4):385-389. PubMed ID: 27848228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody stimulation of the human thyrotropin receptor: regulation of adenylate cyclase activity, thyroglobulin and thyroid peroxidase mRNA levels in primary cultures of Graves' thyroid tissue.
    Collison KS; Banga JP; Barnett PS; Huang GC; McGregor AM
    Clin Exp Immunol; 1991 Oct; 86(1):61-5. PubMed ID: 1914236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pax-8 expression correlates with type II 5' deiodinase expression in thyroids from patients with Graves' disease.
    Ambroziak M; Pachucki J; Chojnowski K; Wiechno W; Nauman J; Nauman A
    Thyroid; 2003 Feb; 13(2):141-8. PubMed ID: 12699588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the thyroid peroxidase gene in human thyroid cells: effect of thyrotrophin, forskolin and phorbol ester.
    Collison KS; Banga JP; Barnett PS; Kung AW; McGregor AM
    J Mol Endocrinol; 1989 Jul; 3(1):1-5. PubMed ID: 2742742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
    Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
    Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Nakazato M; Kogai T; Onaya T
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3331-6. PubMed ID: 9329364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.
    Laurent E; Van Sande J; Ludgate M; Corvilain B; Rocmans P; Dumont JE; Mockel J
    J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters.
    Schuppert F; Deiters S; Rambusch E; Sierralta W; Dralle H; von zur Muhlen A
    Thyroid; 1996 Dec; 6(6):575-87. PubMed ID: 9001192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor autoantibodies induce human thyroid cell growth and c-fos activation.
    Huber GK; Safirstein R; Neufeld D; Davies TF
    J Clin Endocrinol Metab; 1991 May; 72(5):1142-7. PubMed ID: 1850754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma inhibition of human thyrotropin receptor gene expression.
    Nishikawa T; Yamashita S; Namba H; Usa T; Tominaga T; Kimura H; Izumi M; Nagataki S
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1084-9. PubMed ID: 8408457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes that characterize T3-predominant Graves' thyroid tissues.
    Matsumoto C; Ito M; Yamada H; Yamakawa N; Yoshida H; Date A; Watanabe M; Hidaka Y; Iwatani Y; Miyauchi A; Takano T
    Eur J Endocrinol; 2013 Feb; 168(2):137-44. PubMed ID: 23109646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.